IDEAYA Biosciences Inc: About 67% Eye Preservation Rate With Darovasertib Monotherapy Neoadjuvant Uveal Melanoma Treatment
IDEAYA Biosciences Inc:Darovasertib 單一療法新輔助葡萄膜黑色素瘤治療的眼睛保全率約爲 67%
IDEAYA Biosciences Inc: About 67% Eye Preservation Rate With Darovasertib Monotherapy Neoadjuvant Uveal Melanoma Treatment
IDEAYA Biosciences Inc:Darovasertib 單一療法新輔助葡萄膜黑色素瘤治療的眼睛保全率約爲 67%
譯文內容由第三人軟體翻譯。